Dolby Laboratories, Inc.
Bear Case (25th pct.)
-47.8% vs price
Base Case (Median)
-35.6% vs price
Bull Case (75th pct.)
-8.2% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $11.11 | -81.9% | High (40%) |
| PE Comparable | $59.57 | -2.9% | Medium (25%) |
| Growth Trajectory DCF | $53.01 | -13.6% | Medium (20%) |
| Graham Number | $38.03 | -38.0% | Low (10%) |
| EV/EBITDA | $39.49 | -35.6% | Medium (20%) |
| EV/FCF | $71.87 | 17.1% | Medium (20%) |
| Earnings Power Value | $26.00 | -57.6% | Medium (50%) |
Based on 7 out of 8 methods, DLB appears overvalued at the current price of $61.35. The base case fair value of $39.49 implies 35.6% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.